Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

United Therapeutics Net Income 2010-2024 | UTHR

United Therapeutics annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • United Therapeutics net income for the quarter ending March 31, 2024 was $0.307B, a 27.27% increase year-over-year.
  • United Therapeutics net income for the twelve months ending March 31, 2024 was $1.051B, a 44.24% increase year-over-year.
  • United Therapeutics annual net income for 2023 was $0.985B, a 35.4% increase from 2022.
  • United Therapeutics annual net income for 2022 was $0.727B, a 52.86% increase from 2021.
  • United Therapeutics annual net income for 2021 was $0.476B, a 7.58% decline from 2020.
  
United Therapeutics Annual Net Income
(Millions of US $)
2023 $985
2022 $727
2021 $476
2020 $515
2019 $-105
2018 $589
2017 $418
2016 $714
2015 $652
2014 $340
2013 $175
2012 $304
2011 $218
2010 $106
2009 $19
United Therapeutics Quarterly Net Income
(Millions of US $)
2024-03-31 $307
2023-12-31 $217
2023-09-30 $268
2023-06-30 $259
2023-03-31 $241
2022-12-31 $132
2022-09-30 $239
2022-06-30 $116
2022-03-31 $240
2021-12-31 $112
2021-09-30 $163
2021-06-30 $173
2021-03-31 $28
2020-12-31 $99
2020-09-30 $171
2020-06-30 $107
2020-03-31 $138
2019-12-31 $53
2019-09-30 $132
2019-06-30 $205
2019-03-31 $-495
2018-12-31 $65
2018-09-30 $107
2018-06-30 $173
2018-03-31 $245
2017-12-31 $19
2017-09-30 $276
2017-06-30 $-56
2017-03-31 $179
2016-12-31 $110
2016-09-30 $162
2016-06-30 $206
2016-03-31 $236
2015-12-31 $105
2015-09-30 $464
2015-06-30 $99
2015-03-31 $-17
2014-12-31 $116
2014-09-30 $-25
2014-06-30 $112
2014-03-31 $138
2013-12-31 $-30
2013-09-30 $63
2013-06-30 $80
2013-03-31 $62
2012-12-31 $83
2012-09-30 $78
2012-06-30 $72
2012-03-31 $71
2011-12-31 $43
2011-09-30 $84
2011-06-30 $74
2011-03-31 $16
2010-12-31 $10
2010-09-30 $40
2010-06-30 $38
2010-03-31 $19
2009-12-31 $-3
2009-09-30 $12
2009-06-30 $-2
2009-03-31 $13
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $11.320B $2.328B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $72.491B 29.79
Chugai Pharmaceutical (CHGCY) Japan $52.212B 23.34
Takeda Pharmaceutical (TAK) Japan $41.744B 6.76
Merck (MKGAF) Germany $19.917B 18.79
Astellas Pharma (ALPMY) Japan $17.554B 27.71
Sandoz Group AG (SDZNY) Switzerland $14.632B 0.00
Neurocrine Biosciences (NBIX) United States $14.232B 39.40
Shionogi (SGIOY) Japan $13.760B 12.34
Catalent (CTLT) United States $10.135B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.741B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.954B 7.64
Revolution Medicines (RVMD) United States $6.619B 0.00
Ionis Pharmaceuticals (IONS) United States $6.269B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.482B 0.00
Alpine Immune Sciences (ALPN) United States $4.235B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.547B 0.00
Summit Therapeutics (SMMT) United States $3.299B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.871B 0.00
PTC Therapeutics (PTCT) United States $2.620B 0.00
Corcept Therapeutics (CORT) United States $2.486B 22.53
Indivior (INDV) United States $2.431B 11.52
Dyne Therapeutics (DYN) United States $2.226B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.961B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.957B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.879B 11.13
Evotec AG (EVO) Germany $1.860B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.818B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.794B 18.54
Avadel Pharmaceuticals (AVDL) Ireland $1.658B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.593B 27.89
Soleno Therapeutics (SLNO) United States $1.588B 0.00
Ardelyx (ARDX) United States $1.547B 0.00
Xencor (XNCR) United States $1.475B 0.00
4D Molecular Therapeutics (FDMT) United States $1.299B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.287B 12.09
Pacira BioSciences (PCRX) United States $1.254B 12.48
Collegium Pharmaceutical (COLL) United States $1.236B 7.60
Cronos Group (CRON) Canada $1.035B 0.00
Cassava Sciences (SAVA) United States $0.957B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.951B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.943B 0.00
ARS Pharmaceuticals (SPRY) United States $0.904B 0.00
Relay Therapeutics (RLAY) United States $0.881B 0.00
USANA Health Sciences (USNA) United States $0.876B 14.19
Enliven Therapeutics (ELVN) United States $0.851B 0.00
Sage Therapeutics (SAGE) United States $0.799B 0.00
Ocular Therapeutix (OCUL) United States $0.777B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.744B 0.00
Savara (SVRA) United States $0.684B 0.00
Siga Technologies (SIGA) United States $0.663B 9.81
Silence Therapeutics (SLN) United Kingdom $0.641B 0.00
Exscientia (EXAI) United Kingdom $0.621B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.594B 0.00
Lyell Immunopharma (LYEL) United States $0.594B 0.00
OmniAb (OABI) United States $0.534B 0.00
KalVista Pharmaceuticals (KALV) United States $0.514B 0.00
Verve Therapeutics (VERV) United States $0.504B 0.00
Altimmune (ALT) United States $0.501B 0.00
ProKidney (PROK) United States $0.495B 0.00
Korro Bio (KRRO) United States $0.489B 0.00
Larimar Therapeutics (LRMR) United States $0.469B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.429B 0.00
Lexeo Therapeutics (LXEO) United States $0.405B 0.00
Tourmaline Bio (TRML) United States $0.403B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.391B 0.00
Esperion Therapeutics (ESPR) United States $0.386B 0.00
Harrow (HROW) United States $0.369B 0.00
Nature's Sunshine Products (NATR) United States $0.363B 20.33
Heron Therapeutics (HRTX) United States $0.352B 0.00
Organogenesis (ORGO) United States $0.331B 62.75
Fractyl Health (GUTS) United States $0.321B 0.00
Lyra Therapeutics (LYRA) United States $0.320B 0.00
Bioventus (BVS) United States $0.316B 0.00
Black Diamond Therapeutics (BDTX) United States $0.310B 0.00
Aquestive Therapeutics (AQST) United States $0.306B 0.00
Nektar Therapeutics (NKTR) United States $0.303B 0.00
ESSA Pharma (EPIX) Canada $0.293B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.291B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.287B 0.00
Nanobiotix S.A (NBTX) France $0.283B 0.00
Metagenomi (MGX) United States $0.264B 0.00
Akebia Therapeutics (AKBA) United States $0.260B 0.00
Xeris Biopharma Holdings (XERS) United States $0.259B 0.00
Pyxis Oncology (PYXS) United States $0.259B 0.00
Aldeyra Therapeutics (ALDX) United States $0.250B 0.00
Foghorn Therapeutics (FHTX) United States $0.249B 0.00
Adherex Technologies (FENC) United States $0.246B 0.00
Avita Medical (RCEL) United States $0.223B 0.00
Galectin Therapeutics (GALT) United States $0.217B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Eliem Therapeutics (ELYM) United States $0.210B 0.00
Conduit Pharmaceuticals (CDT) United States $0.208B 0.00
Telomir Pharmaceuticals (TELO) United States $0.202B 0.00
Zevra Therapeutics (ZVRA) United States $0.200B 0.00
Century Therapeutics (IPSC) United States $0.197B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.191B 0.00
Acrivon Therapeutics (ACRV) United States $0.186B 0.00
MediWound (MDWD) Israel $0.183B 0.00
Profound Medical (PROF) Canada $0.182B 0.00
Incannex Healthcare (IXHL) Australia $0.169B 0.00
Regulus Therapeutics (RGLS) United States $0.164B 0.00
Prelude Therapeutics (PRLD) United States $0.157B 0.00
Achieve Life Sciences (ACHV) Canada $0.155B 0.00
Cardiol Therapeutics (CRDL) Canada $0.141B 0.00
Elite Pharmaceuticals (ELTP) United States $0.138B 12.91
CytoDyn (CYDY) United States $0.135B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.131B 2.76
Karyopharm Therapeutics (KPTI) United States $0.126B 0.00
VAXART, INC (VXRT) United States $0.124B 0.00
FibroGen (FGEN) United States $0.116B 0.00
Citius Pharmaceuticals (CTXR) United States $0.116B 0.00
Relmada Therapeutics (RLMD) United States $0.111B 0.00
GlycoMimetics (GLYC) United States $0.104B 0.00
OptiNose (OPTN) United States $0.103B 0.00
Inotiv (NOTV) United States $0.101B 0.00
PMV Pharmaceuticals (PMVP) United States $0.096B 0.00
ProPhase Labs (PRPH) United States $0.094B 0.00
AlloVir (ALVR) United States $0.093B 0.00
Vivani Medical (VANI) United States $0.091B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.091B 0.00
Aclaris Therapeutics (ACRS) United States $0.090B 0.00
Assertio Holdings (ASRT) United States $0.088B 7.09
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.081B 0.00
Tempest Therapeutics (TPST) United States $0.080B 0.00
Journey Medical (DERM) United States $0.070B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.97
Mural Oncology (MURA) Ireland $0.064B 0.00
Jaguar Animal Health (JAGX) United States $0.062B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.057B 0.00
BioLineRx (BLRX) Israel $0.054B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Unicycive Therapeutics (UNCY) United States $0.043B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
ElectroCore (ECOR) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.036B 0.00
Protara Therapeutics (TARA) United States $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
CASI Pharmaceuticals (CASI) China $0.032B 0.00
Surrozen (SRZN) United States $0.032B 0.00
JanOne (JAN) United States $0.031B 0.00
DURECT (DRRX) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
Nutriband (NTRB) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lipocine (LPCN) United States $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
PolyPid (PYPD) Israel $0.024B 0.00
NRx Pharmaceuticals (NRXP) United States $0.023B 0.00
TherapeuticsMD (TXMD) United States $0.022B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 1.03
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.020B 9.47
BioVie (BIVI) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Avalo Therapeutics (AVTX) United States $0.017B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Clever Leaves Holdings (CLVR) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.34
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 45.53